QTREX Quantum Ltd.
QTEX · XNASCIK 1837493fmd_1D8ED8VDP8FBGCPJPM6AWX4YHQManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2019 to Dec 31, 2025, 13 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 0 | 0 | 0 |
| Cost of revenue | – | – | – | – | 0 | 0 | 0 |
| Gross profit | – | – | – | – | 0 | 0 | 0 |
| Research and development | – | – | 4 | 8 | 7 | 6 | 7 |
| Selling, general and administrative | – | – | 9 | 7 | 5 | 5 | 6 |
| Compensation and benefits | – | – | 2 | 3 | 4 | 4 | 4 |
| Total benefits, losses and expenses | – | – | – | – | 1 | – | – |
| Operating income | 1 | 6 | (13) | (15) | (12) | (11) | (14) |
| Non-interest expense | – | – | – | – | 1 | – | – |
| Interest expense | – | – | – | – | 1 | – | – |
| Other non-operating income (expense) | – | – | (4) | (0) | 1 | 0 | 0 |
| Income before taxes | 5 | 7 | (17) | (15) | (11) | (11) | (13) |
| Income tax expense | – | – | – | – | 0 | 0 | 0 |
| Net income from continuing operations | 5 | 7 | 17 | 10 | (11) | (11) | (13) |
| Net income | (5) | 17 | (17) | (15) | (11) | (11) | (13) |